iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Data Tools >
Price & News Alerts
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
Sophiris Bio, Inc. (SPHS)
Add SPHS Price Alert
Search This Board:
9/17/2017 6:42:03 PM
- Board type:
- Posts Today:
Sophiris Bio Inc.
Sophiris Bio Inc. is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a large unsatisfied market. PRX302, the company’s lead candidate for BPH, is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. Sophiris is planning to begin a pivotal trial by the end of 2012.
The pivotal trial is supported by a randomized, controlled Phase IIb study that met the objective and subjective endpoints used as the basis for current BPH drug approvals. Sophiris is advised by world-leading urologists, is backed by experienced investors, and is led by an experienced drug development team that has achieved more than twenty drug approvals including several blockbusters.
Ongoing Clinical Development
III On-going/Enrollment Completed (479 patients)
Prospective, randomized, double-blind, placebo-controlled, transrectal treatment of PRX302, which will utilize the IPSS outcome measure evaluated at 12 months as the primary endpoint
IIa Enrolling (approximately 20 patients)
Open label, Phase 2a study, evaluating the safety and tolerability of targeted intraprostatic administration of PRX302 to treat men with histologically proven, clinically significant, localized, low to intermediate risk prostate cancer
Completed Clinical Development
(pts treated with PRX302
IIb (61 pts)
Randomized, double-blind, placebo-controlled, transperineal treatment of PRX302
I/II (32 pts)
Randomized dose escalation, multicenter trial of a single transrectal intraprostatic treatment of PRX302
Phase 2a BPH
IIa (18 pts)
Open-label, safety, volume escalation clinical trial of a single transperineal treatment of PRX302
I (15 pts)
Open-label, safety, dose escalation clinical trial of a signal transperineal intraprostatic treatment of PRX302
I (24 pts)
Open-label, safety and tolerability, dose escalation trial of PRX302 in patients with biopsy-proven, locally-recurrent prostate cancer
II (6 pts)
Open-label clinical trial in locally-recurrent prostate cancer
$SPHS was $40.00 in 2011 We will be back there soon enough.
SPHS Detailed Quote
SPHS News: Current Report Filing (8-k)
09/13/2017 04:09:44 PM
SPHS News: Sophiris Bio Secures up to $10 Million in Term Loans from Silicon Valley Bank
09/13/2017 04:05:00 PM
SPHS News: Notice of Effectiveness (effect)
08/31/2017 06:02:22 AM
SPHS News: Securities Registration Statement (simplified Form) (s-3/a)
08/24/2017 04:37:04 PM
SPHS News: Sophiris Bio to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
08/17/2017 08:00:00 AM
Post New Msg
My Stocks (117)
09/17/17 06:42:03 PM
BurntNAlive, Thanks for the information, and definitely it is
09/17/17 04:43:10 PM
Expecting this to fly during 1 qtr of
09/16/17 06:05:02 PM
I bought sphs when it was less than
09/16/17 12:25:28 PM
Love this company soon will save people lives.
08/15/17 06:59:19 PM
08/10/17 07:04:50 PM
August 8th -15th not confirmed.
07/28/17 05:19:47 PM
When do we expect it?
07/28/17 12:14:23 PM
Should expect news soon coming into earnings report.
07/27/17 05:13:53 PM
07/25/17 05:56:19 PM
Excellent article. Just wish it put Sophiris' name
07/24/17 08:20:45 PM
07/23/17 03:43:10 PM
Yes far more active!
07/11/17 05:14:09 PM
Thanks for introducing me to stock twits it's
07/11/17 04:10:06 PM
What a let down this week..
07/07/17 05:56:44 PM
Dude get stock twits...
07/06/17 04:42:26 AM
Sphs CEO article click June 27th https://www.linkedin.com/pulse/seeing-hard-re
07/05/17 11:26:36 PM
07/05/17 11:25:05 PM
Hoping for some merger news this year.
07/05/17 11:09:15 PM
Happy 4th of July everyone hope for some
07/04/17 03:10:28 PM
Lol very funny you wish to get 1.40s..
07/03/17 02:47:16 PM
07/02/17 10:24:32 PM
Waiting on the 1.40's to cover and go long.
07/02/17 10:22:02 PM
Let's continue this uptrend all week show some
06/27/17 07:10:38 PM
06/26/17 07:59:54 PM
Bring me some good news today $ph $
06/26/17 09:22:28 AM
the company interested would not need to wait
06/25/17 05:07:44 PM
I believe partnership will be done before a
06/25/17 01:12:48 PM
But you know this can go $4 plus
06/25/17 11:13:09 AM
Is there any chance $sphs will announce dilution
06/25/17 09:56:39 AM
Thank You! I am waiting for the institutions
06/24/17 02:42:48 AM
I certainly hope so. I believe in SPHS
06/24/17 01:36:00 AM
Small caps usually perform better on the Russell.
06/23/17 07:34:24 PM
How this would help? I have lot of
06/23/17 06:50:21 PM
From next week a different sphs. Russell
06/23/17 04:25:37 PM
Keep pushing shorts just keep loading up shorts please..
06/13/17 08:18:55 PM
Let's hope. Holding 15.5 k shares here still
06/12/17 01:49:43 PM
Yes yes of course, I believe sphs
06/12/17 01:21:06 PM
You were holding the line during the roughest
06/12/17 09:40:21 AM
I am coming back soon don't mind buying
06/12/17 08:53:18 AM
I just can't believe you abandoned xxii. Xxii
06/12/17 08:37:48 AM
Wake up SPHS..
06/07/17 05:07:21 PM
Thank you good luck to you as well,
06/05/17 07:40:42 PM
No problem good luck hope you take profits
06/05/17 07:28:40 PM
Or it's at .30 easy ;). I'm not
06/05/17 07:18:26 PM
But you know how these bio works right?
06/05/17 07:17:30 PM
Absolutely. I have plenty of wiggle room. Been
06/05/17 06:51:56 PM
$PH $ healthy long term..
06/05/17 06:51:33 PM
But hey more of you better for me
06/05/17 06:50:38 PM
I feel sorry for you did you. You
06/05/17 06:49:51 PM
Post New Msg
My Stocks (117)
© 2017 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
Personal Finance Q&A
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App